Cytokeratin 8 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cytokeratin 8 monoclonal antibodies to support research needs. Cytokeratin 8 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cytokeratin 8 is a type of intermediate filament protein that maintains the structural integrity of epithelial cells. Cytokeratin 8 participates in essential cellular processes, including cell signaling, differentiation, and apoptosis. Research has shown that Cytokeratin 8 expression levels can indicate tumor progression and metastasis, making it a significant focus in cancer studies. Cytokeratin 8 monoclonal antibodies enable researchers to explore molecular pathways and cellular mechanisms in both normal and disease states. Understanding Cytokeratin 8's function has led to significant discoveries in epithelial cell biology and cancer research. Cytokeratin 8 monoclonal antibodies from Santa Cruz Biotechnology continue to advance scientific understanding of cellular processes and disease mechanisms, supporting researchers worldwide in their pursuit of new therapeutic strategies.